SEC Form 4 · accession 0001225208-15-000535
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Young
Officer — Group President
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2014 | M | 26,767 | $18.19 | A | 128,860 | D | |
| Common StockF2 | Dec 31, 2014 | F | 7,368 | $31.15 | D | 121,492 | D | |
| Common StockF3,F4 | Dec 31, 2014 | F | 11,703 | $31.54 | D | 109,789 | D | |
| Common Stock | holding | — | — | — | 1,083 | I | By Rule 16b-3 Plan | |
| Common Stock | holding | — | — | — | 1,309 | I | By Trustee under the Pfizer Share Ownership Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights | $18.19 | Dec 31, 2014 | M | 26,767 | D | Dec 31, 2014 | Dec 31, 2014 | Common Stock | 26,767 | 0 | D |
Explanation of responses
- F1The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- F2The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- F3The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- F4Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.